Scoping out better ways to treat early esophageal cancer
NCT ID NCT07343869
Summary
This study aims to track the real-world results of a minimally invasive procedure called endoscopic submucosal dissection (ESD) for treating early-stage esophageal cancer. It will follow 750 patients across multiple French hospitals for five years to see how well the treatment works, how often cancer comes back, and what factors lead to the best outcomes. The goal is to gather evidence from everyday practice to help doctors make better decisions for patients with these early cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETTS ESOPHAGUS WITH DYSPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jules Verne Clinic
Nantes, 44300, France
Conditions
Explore the condition pages connected to this study.